Elsevier

Journal of Hepatology

Volume 50, Issue 2, February 2009, Pages 314-322
Journal of Hepatology

Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation,☆☆

https://doi.org/10.1016/j.jhep.2008.10.018Get rights and content

Background/Aims

Graft re-infection invariably occurs after liver transplantation (OLT) for chronic hepatitis C and disease progression is unpredictable. We prospectively examined peripheral blood mononuclear cells (PBMC) subsets and natural killer (NK) cell receptors (NKRs) in patients with recurrent hepatitis C post-OLT.

Methods

PBMC were obtained at baseline and at different time points after OLT. NKRs were identified using monoclonal antibodies by flow cytometry.

Results

The proportions of NK, natural T (NT), total and γδ T cells were significantly reduced (p < 0.01) 7 days post-transplant, probably as a result of graft repopulation. NKG2D+ NK cells were significantly higher compared with healthy controls (p < 0.01), declined post-OLT and subsequently returned to baseline values. This, together with a progressive increase in the proportion of CD94/NKG2C+ NK cells over time (p  0.01), appeared to be related to hepatitis C recurrence. There was a statistically significant correlation between expression of the natural cytotoxicity receptors (NCRs) and ALT (p < 0.05), supporting the hypothesis that NK cells participate in the necroinflammatory process.

Conclusions

The data are compatible with homing of immune cells to the liver allograft after surgery, most of which return to pre-OLT levels. HCV recurrence may cause variations in selected NKRs expression akin to other viral infections.

Introduction

Graft re-infection occurs immediately after liver transplantation (OLT) for end-stage liver disease caused by chronic hepatitis C virus (HCV) infection; however, disease progression may rapidly develop and is often unpredictable. Indeed, allograft cirrhosis occurs in up to 30% of liver transplant recipients in the 5 years following surgery, with ensuing graft failure and need for re-transplantation [1]. The causes for such a rapid progression are largely unknown, although it may be inferred that accumulation of highly pathogenic HCV variants associated with dysfunctional host immune responses secondary to immune suppression may be responsible for this phenomenon. Previous findings suggested a role for adaptive immunity in the control of HCV re-infection post-transplant [2], [3]. A possible role for innate immunity has recently been explored only before OLT [4]. However, a systematic prospective study of innate immune cell frequencies and phenotype has never been performed. The importance of innate immune cells is further emphasized by the observation that natural killer (NK) and natural T (NT) cells are uniquely enriched in the inflammatory cell infiltrate of the diseased liver [5], [6]. Moreover, NK cell frequencies have been reported to be reduced in patients with chronic HCV infection [7], [8], [9], [10], but whether this translates into altered function is still controversial [10], [11], [12]. To assess whether variations in the frequency and phenotype of NK and NT cells were associated with clinical, biochemical and virological indicators of disease severity and progression, we prospectively examined these cells in patients with recurrent hepatitis C post-OLT and controls. We found that, in general, modifications of innate and adaptive immune cell frequencies occurred predominantly in the early phase post-transplant, and returned to baseline levels starting from one month after surgery. Prospective phenotypic changes in natural killer receptors (NKRs) were instead solely restricted to NK cells.

Section snippets

Patients

Twenty patients with HCV-related cirrhosis (18 males, median age 57 years, range 43–67 years) who underwent liver transplantation between July 2004 and July 2006 were enrolled in the study. Ten patients had associated hepatocellular carcinoma, 13 (65%) patients were infected with genotype 1b or 1a, 5 (25%) with genotype 3 and 2 (10%) with genotype 2a/c (INNO-LiPA, HCV II (Bayer Corp., Tarrytown, NY, USA). All patients were serum HCV RNA positive by the quantitative Versant HCV RNA 3.0 bDNA

Proportions of circulating lymphocyte subsets before and after OLT in patients with HCV-induced cirrhosis

We prospectively evaluated the proportions of peripheral blood NK cells, NT cells, total T and B lymphocytes and γδ T cells in patients with chronic HCV infection undergoing liver transplantation, at baseline and at different time points up to one year post-OLT. NK and NT cell phenotypes were also simultaneously analysed using NKR-specific mAbs. There were no statistically significant differences in the proportion of all circulating lymphocyte subsets between HCV+ patients before OLT and

Discussion

HCV recurrence after OLT significantly accelerates progression to allograft cirrhosis. However, current clinical, biochemical and histological indicators to monitor progression of chronic HCV after OLT lack adequate specificity and sensitivity. In addition, the immunopathogenesis of liver disease and the role of host cellular immune responses in this setting are largely undefined.

Cells of the immune system can be classified as innate or adaptive. All myeloid cells and some lymphocytes,

Acknowledgements

This work was supported by a grant from the Italian Ministry of Education, University and Research MIUR (Progetti di Ricerca di Interesse Nazionale-PRIN), by Research Funds of the Italian Ministry of Health (Ricerca Corrente, Fondazione IRCCS Policlinico San Matteo), by an unrestricted research grant from Schering-Plough, Italy, by COPEV Associazione per la Prevenzione e Cura dell’Epatite Virale Beatrice Vitiello ONLUS, and by a generous donation from Mr. Maurizio Traglio. We thank Prof.

References (37)

  • M. Gumá et al.

    Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts

    Blood

    (2006)
  • S.J. Weston et al.

    Reconstitution of hepatitis C virus-specific T-cell mediated immunity after liver transplantation

    Hepatology

    (2005)
  • N.H. Gruener et al.

    Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation

    Liver Transpl

    (2004)
  • H.R. Rosen et al.

    Pretransplantation CD56+ innate lymphocyte populations associated with severity of hepatitis C recurrence

    Liver Transpl

    (2008)
  • D.G. Doherty et al.

    Innate and adaptive lymphoid cells in the human liver

    Immunol Rev

    (2000)
  • G. Szabo et al.

    Altered innate immunity in chronic hepatitis C infection – cause or effect?

    Hepatology

    (2007)
  • J. Corado et al.

    Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection

    Clin Exp Immunol

    (1997)
  • U.C. Meier et al.

    Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections

    J Virol

    (2005)
  • Cited by (16)

    • Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections

      2009, Gastroenterology
      Citation Excerpt :

      NK cells were identified in PBMC as CD3−/CD20−/CD56+ and could be easily defined as CD56dim and CD56bright according to fluorescence intensity. Expression of several activating (NKG2D, CD94/NKG2C, NKp44, NKp46, and NKp30) and inhibitory (IRP60, CD94/NKG2A, KIR2DL1, KIR2DL2, KIR3DL1, LIR1/ILT2, p75/AIRM1) NKRs, as well as coreceptors (2B4, NTB-A, NKp80, DNAM.1) and early activation molecules (CD69) was examined by labelling with monoclonal antibodies (mAbs) as described previously.21 In addition, a detailed analysis of single inhibitory receptor expression was carried out using PE-conjugated IgG1 mAbs specific for KIR2DL2/DL3/DS2 (CD158 b1,b2,j), KIR2DL1/DS1 (CD158 a,h), KIR3DL1/DS1 (Z27, CD158 e1,e2), and ILT2 (CD85), all from Beckman Coulter, Fullerton, CA.

    View all citing articles on Scopus

    The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

    ☆☆

    Presented in part at the 43rd EASL Annual Meeting and published in abstract form.

    These authors contributed equally to this work.

    View full text